{"id":"intra-ovarian-by-platelet-rich-plasma","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian pain or discomfort"},{"rate":null,"effect":"Mild bleeding or bruising at injection site"},{"rate":null,"effect":"Infection risk"}]},"_chembl":{"chemblId":"CHEMBL2108774","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PRP contains concentrated platelets and growth factors (PDGF, VEGF, FGF, IGF-1) that promote tissue regeneration and angiogenesis. When injected directly into ovarian tissue, these bioactive molecules are hypothesized to enhance ovarian reserve, improve egg quality, and restore ovarian function in women with diminished ovarian reserve or premature ovarian failure.","oneSentence":"Platelet-rich plasma (PRP) injected intra-ovarian delivers growth factors and cytokines to stimulate ovarian function and improve fertility outcomes.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:16:36.552Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diminished ovarian reserve"},{"name":"Premature ovarian failure / Primary ovarian insufficiency"},{"name":"Infertility associated with low ovarian function"}]},"trialDetails":[{"nctId":"NCT06048666","phase":"PHASE3","title":"Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-10-30","conditions":"IVF","enrollment":56},{"nctId":"NCT04444245","phase":"PHASE1","title":"Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF","status":"UNKNOWN","sponsor":"Black Tie Medical, Inc.","startDate":"2022-07-15","conditions":"Ovarian Failure, Perimenopausal Disorder, Hormone Disturbance","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intra ovarian by platelet rich plasma","genericName":"Intra ovarian by platelet rich plasma","companyName":"Beni-Suef University","companyId":"beni-suef-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"Platelet-rich plasma (PRP) injected intra-ovarian delivers growth factors and cytokines to stimulate ovarian function and improve fertility outcomes. Used for Diminished ovarian reserve, Premature ovarian failure / Primary ovarian insufficiency, Infertility associated with low ovarian function.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}